SCHEMBL7801154

SCHEMBL7801154

CC(C)CC/C=C(\N)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.36
GRIK1 P39086 1/20 0.35
ALOX15 P16050 1/20 0.35
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
CA1 P00915 1/20 0.33
BLM P54132 1/20 0.32
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32
GABRA2 P47869 2/20 0.32
GABRB2 P47870 2/20 0.32
GABRA4 P48169 2/20 0.32
GABRE P78334 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7801162 1.00 KDM1A (0.36) KDM1AGRIK1ALOX15SLC1A3SLC1A2
SCHEMBL6544850 0.77 GRIK1 (0.50) GRIK1SLC1A3SLC1A2GABRPGABRD
SCHEMBL8519655 0.77 KDM1A (0.38) KDM1AGRIK1ALOX15SLC1A3SLC1A2
SCHEMBL27628 0.76 KDM1A (0.41) KDM1AALOX15CA1BLM
SCHEMBL574289 0.76 KDM1A (0.41) KDM1AALOX15CA1BLM
SCHEMBL3293228 0.75
SCHEMBL1275230 0.75
SCHEMBL3235405 0.74 KDM1A (0.36) KDM1AALOX15SLC1A3SLC1A2SLC1A1
SCHEMBL3235392 0.74 KDM1A (0.36) KDM1AALOX15SLC1A3SLC1A2SLC1A1
Butane SCHEMBL9158346 0.73 GRIK1 (0.46) GRIK1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906333-B1 SUBSTRATES AND INHIBITORS OF PROTEOLYTIC ENZYMES MEDIVIR UK LTD (GB) 2001-07-25 EP disclosed
EP-0839155-A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES PEPTIDE THERAPEUTICS LIMITED (GB) 1998-05-06 EP disclosed
WO-1997004004-A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES PEPTIDE THERAPEUTICS LIMITED (GB) 1997-02-06 WO disclosed